- Trials with a EudraCT protocol (320)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
320 result(s) found for: Graft Rejection.
Displaying page 1 of 16.
EudraCT Number: 2008-003231-20 | Sponsor Protocol Number: BE-02-RG-186 | Start Date*: 2008-11-26 | |||||||||||
Sponsor Name:KULeuven | |||||||||||||
Full Title: Adherence Measurement in stable renal transplant patients following conversion form Prograft to advagraf | |||||||||||||
Medical condition: Renal transplant patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000441-12 | Sponsor Protocol Number: 0624-201 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:VIROPHARMA Incorporated | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled pilot study to evaluate the safety and effect of Cinryze (C1 Esterase Inhibitor (Human)) for the treatment of acute antibody-mediated rejection in rec... | |||||||||||||
Medical condition: Acute Antibody Mediated Rejection (AMR) in kidney transplant patients | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000889-22 | Sponsor Protocol Number: ICKTI08TX01 | Start Date*: 2008-11-11 | |||||||||||
Sponsor Name:Imperial College Healthcare NHS Trust | |||||||||||||
Full Title: A randomised controlled comparison of standard release Tacrolimus vs extended-release Tacrolimus as baseline maintenance monotherapy for kidney transplantation after induction with Campath 1-H. | |||||||||||||
Medical condition: Prevention of allograft rejection after renal transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002825-52 | Sponsor Protocol Number: CRAD001A2401T | Start Date*: 2014-04-03 | |||||||||||
Sponsor Name:Medizinische Hochschule Hannover | |||||||||||||
Full Title: Single-center, open-label, single-arm Phase IIa study in kidney transplant patients with acute T-cell-mediated rejection in renal transplant according to Banff criteria (class IA and IB) without (s... | |||||||||||||
Medical condition: Acute cellular rejection after kidney transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002914-20 | Sponsor Protocol Number: RRK3367 | Start Date*: 2007-09-20 | ||||||||||||||||
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | ||||||||||||||||||
Full Title: Calcineurin Inhibitor Minimisation in Renal Transplant Recipients with Stable Allograft Function: A Prospective Randomised Controlled Trial | ||||||||||||||||||
Medical condition: Renal Transplantation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012350-20 | Sponsor Protocol Number: MSC-KTx | Start Date*: 2008-01-14 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: MESENCHYMAL STEM CELLS UNDER BASILIXIMAB/ LOW DOSE RATG TO INDUCE RENAL TRANSPLANT TOLERANCE | |||||||||||||
Medical condition: Patients will be those receiving a living-related kidney transplant | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002310-22 | Sponsor Protocol Number: 35/2008/O/Sper | Start Date*: 2008-06-16 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: A multicenter phase II trial of Recipient pre-treatment with Short-Term Rapamycin for the prevention of acute GVHD after hematopoietic stem cell transplantation in Elderly Patients | ||||||||||||||||||
Medical condition: Graft Versus Host Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005604-14 | Sponsor Protocol Number: AIFA TX | Start Date*: 2006-12-19 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: A randomized, prospective, multicenter trial to compare the effect on chronic allograft nephropathy prevention of mycophenolate mofetil versus azathioprine as the sole immunosuppressive therapy f... | |||||||||||||
Medical condition: kidney transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004777-49 | Sponsor Protocol Number: 20-HMedIdeS-18 | Start Date*: 2020-12-17 | |||||||||||
Sponsor Name:Hansa Biopharma | |||||||||||||
Full Title: A prospective, observational long-term follow-up trial of kidney transplant patients treated with imlifidase or plasma exchange after an active/chronic active Antibody-Mediated Rejection episode | |||||||||||||
Medical condition: Antibody-mediated rejection in kidney transplant patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) AT (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000793-30 | Sponsor Protocol Number: PedTac | Start Date*: 2013-10-22 | ||||||||||||||||
Sponsor Name:Oslo University Hospital - Rikshospitalet | ||||||||||||||||||
Full Title: The PedTac study Development of a pediatric pharmacokinetic population model for Tacrolimus | ||||||||||||||||||
Medical condition: Solid organ transplantation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: NO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003089-11 | Sponsor Protocol Number: ICI21/00042 | Start Date*: 2022-03-08 | ||||||||||||||||
Sponsor Name:Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC) | ||||||||||||||||||
Full Title: Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING Study | ||||||||||||||||||
Medical condition: Subclinical inflammation, including borderline lesions (BL), is very common after kidney transplantation (KT), even in low immunological risk patients, and can lead to interstitial fibrosis/tubular... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002856-34 | Sponsor Protocol Number: LTx18-01 | Start Date*: 2019-03-01 | |||||||||||
Sponsor Name:Foundation for Liver research | |||||||||||||
Full Title: Modifying tacrolimus related toxicity after liver transplantation. A randomized controlled trial comparing Envarsus® and Advagraf® in de novo liver transplant recipients. | |||||||||||||
Medical condition: liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000295-16 | Sponsor Protocol Number: LX201-01 | Start Date*: 2007-07-27 | |||||||||||
Sponsor Name:Lux Biosciences, Inc. | |||||||||||||
Full Title: A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 FOR PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES AND GRAFT FAILURE... | |||||||||||||
Medical condition: Patient after penetrating keratoplasty who are at increased immunological risk for corneal allograft rejection episodes and/or graft failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002330-38 | Sponsor Protocol Number: RituxiCAN-C4 | Start Date*: 2006-11-22 | |||||||||||
Sponsor Name:King's College London | |||||||||||||
Full Title: Randomised Trial of Anti-CD20 in C4d+ Chronic Allograft Nephropathy | |||||||||||||
Medical condition: Renal Transplant Rejection - chronic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004302-10 | Sponsor Protocol Number: Intercept | Start Date*: 2020-08-19 | |||||||||||
Sponsor Name:Västra Götalandsregionen, Sahlgrenska University hospital | |||||||||||||
Full Title: A randomized controlled open-label multi-center study to assess the efficacy of Tocilizumab in treatment of chronic active antibody-mediated rejection in kidney transplant recipients | |||||||||||||
Medical condition: Treatment of chronic active antibody-mediated rejection in kidney transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004650-25 | Sponsor Protocol Number: ECU-DGF-201 | Start Date*: 2014-08-12 | |||||||||||
Sponsor Name:Alexion Pharmaceuticals Incorporated | |||||||||||||
Full Title: A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multi-Center Study of Eculizumab for the Prevention of Delayed Graft Function after Kidney Transplantation in Adult Subjects at Incre... | |||||||||||||
Medical condition: Delayed Graft Function | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) ES (Completed) CZ (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004695-20 | Sponsor Protocol Number: ML19313 | Start Date*: 2006-03-27 | |||||||||||
Sponsor Name:Roche Pharma AG | |||||||||||||
Full Title: Randomized multicenter trial comparing Valganciclovir CMV prophylaxis versus pre-emptive therapy after renal transplantation using proteomics for monitoring of graft alteration | |||||||||||||
Medical condition: Prevention of cytomegalovirus (CMV) disease in kidney transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004301-24 | Sponsor Protocol Number: ONErgt11 | Start Date*: 2012-01-05 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Free State of Bavaria, represented by the University of Regensburg, represented by Prof. Edward K. Geissler | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation – Reference Group Trial | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Kidney allograft rejection following living-donor renal transplantation. | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) FR (Completed) IT (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-005109-20 | Sponsor Protocol Number: CRAD001ADE19 | Start Date*: 2009-06-09 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: 6-month, open-label, randomized, multicenter, prospective, controlled study to evaluate the efficacy, safety and tolerability of Everolimus in de novo renal transplant recipients participating in t... | |||||||||||||
Medical condition: renal transplantation | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010640-34 | Sponsor Protocol Number: THYTOTRA | Start Date*: 2009-08-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: INDUCTION OF DONOR-SPECIFIC TOLERANCE IN PATIENTS WITH LIVER TRANSPLANTATION WITH RECIPIENT PRE-TREATMENT WITH THYMOGLOBULINE AND MINIMAL POST-TRANSPLANT IMMUNOSUPPRESSION. | |||||||||||||
Medical condition: Adult recipients of first liver transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.